Paper Details

  1. Home
  2. Paper Details

Topical paricalcitol (19-nor-1 alpha,25-dihydroxyvitamin D2) is a novel, safe and effective treatment for plaque psoriasis: a pilot study.

Author: DurakovicC, HolickM F, RayS

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, U.S. Gov't, P.H.S.Research funding provided by the Public Health Service (PHS).

Overview

New treatments are still needed for psoriasis. Topical vitamin D compounds have proven safe and effective for psoriasis. Paricalcitol, a new type of vitamin D, has been developed to prevent a condition affecting the parathyroid glands in people with kidney failure.
Paper Details　
Original Abstract of the Article :
There continues to be a need to develop new pharmacological approaches for treating psoriasis. Topical active vitamin D compounds have proven to be both safe and effective for treating psoriasis. Paricalcitol (19-nor-1 alpha,25-dihydroxyvitamin D(2)) is a novel vitamin D analogue which has been deve...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/15270890

データ提供：米国国立医学図書館（NLM）

Topical Paricalcitol for Psoriasis: A Desert Oasis of Relief

This research explores the potential benefits of [topical paricalcitol] for treating [psoriasis], a chronic skin condition that can cause significant discomfort and affect quality of life. Imagine [psoriasis] as a desert of itchy, scaly patches, a constant source of irritation. The authors conducted a pilot study to assess the safety and efficacy of topical paricalcitol, a [vitamin D analogue], in treating psoriasis, offering a potential new approach to managing this challenging condition.

Topical Paricalcitol: A Desert Oasis of Hope

This pilot study demonstrates the potential of [topical paricalcitol] as a safe and effective treatment option for [psoriasis]. The study highlights the ability of this [vitamin D analogue] to effectively reduce the symptoms of psoriasis, offering a potential alternative to existing treatment modalities. While further research is needed to fully assess the long-term benefits and risks of this medication, this study offers a glimmer of hope for individuals seeking relief from this challenging condition.

Managing Psoriasis: A Desert Oasis of Knowledge

This research underscores the importance of exploring a variety of treatment options for managing [psoriasis]. It highlights the potential benefits of [topical paricalcitol], a [vitamin D analogue], offering a potential new avenue for addressing this chronic skin condition. This study encourages continued research and exploration of innovative therapies to improve treatment outcomes and enhance the quality of life for individuals living with psoriasis.

Dr. Camel's Conclusion

This research is like a wellspring of hope in the desert of [psoriasis]. It highlights the potential benefits of [topical paricalcitol], a [vitamin D analogue], in managing this complex condition. While the study acknowledges the need for further research, it underscores the importance of exploring innovative therapies to improve the lives of individuals with psoriasis. Remember, even in the most challenging deserts, there is always the potential for an oasis of hope.
Date :
  1. Date Completed 2004-10-19
  2. Date Revised 2015-11-19
Further Info :

Pubmed ID

15270890

DOI: Digital Object Identifier

BJD6002

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.